- Home
- CATX vs ASPN Comparison
CATX vs ASPN Comparison
Compare CATX & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CATX | ASPN |
|---|---|---|
| Founded | 1983 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.4M | 573.2M |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CATX | ASPN |
|---|---|---|
| Price | $4.96 | $3.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $12.20 | $4.25 |
| AVG Volume (30 Days) | ★ 1.7M | 1.6M |
| Earning Date | 04-28-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.31 | ★ 125.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $452,699,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $38.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 89.64 |
| 52 Week Low | $1.60 | $2.30 |
| 52 Week High | $6.16 | $9.78 |
Technical Indicators
Market Signals| Indicator | CATX | ASPN |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 46.75 |
| Support Level | $3.24 | $2.89 |
| Resistance Level | $5.39 | $3.80 |
| Average True Range (ATR) | 0.41 | 0.27 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 33.21 | 64.46 |
Price Performance
Historical ComparisonAbout CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.